PHARYNGEAL CANCER

This adverse event was reported 177 times

These drugs are most commonly taken by patients reporting PHARYNGEAL CANCER:

# Drug Count
0 INFLIXIMAB 8
1 ADALIMUMAB 7
2 ETANERCEPT 7
3 ENZALUTAMIDE 6
4 VALSARTAN 6
5 AMLODIPINE 5
6 APIXABAN 5
7 LORAZEPAM 5
8 METHOTREXATE SODIUM 5
9 TOFACITINIB 5
See all common drugs associated with PHARYNGEAL CANCER

PHARYNGEAL CANCER is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 POLYMYXIN B SULFATE AND TRIMETHOPRIM SULFATE 1 0.0061
1 CASTOR OIL 1 0.0052
2 REPOTRECTINIB 1 0.0036
3 MEXILETINE HYDROCHLORIDE 1 0.0024
4 AMOXAPINE 1 0.0021
5 STANDARDIZED SENNA CONCENTRATE AND DOCUSATE SODIUM 2 0.0014
6 DAPRODUSTAT 1 0.0005
7 PILOCARPINE HYDROCHLORIDE 1 0.0004
8 INSULIN ASPART INJECTION 1 0.0004
9 ETELCALCETIDE 1 0.0003
See all drugs enriched for association with PHARYNGEAL CANCER